Financial reports
ARS
2023 FY
Annual report to shareholders
26 Apr 24
10-K/A
2023 FY
Annual report (amended)
22 Apr 24
10-K
2023 FY
Annual report
28 Mar 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
10-K
2022 FY
Annual report
16 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
Current reports
8-K
1THE ONCOLOGY INSTITUTE OF HOPE & INNOVATION Investor Presentation April 2024
3 Apr 24
8-K
The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024
27 Mar 24
8-K
The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance
8 Nov 23
8-K
Other Events
18 Sep 23
8-K
Departure of Directors or Certain Officers
6 Sep 23
8-K
Departure of Directors or Certain Officers
1 Sep 23
8-K
Other Events
30 Aug 23
8-K
1THE ONCOLOGY INSTITUTE OF HOPE & INNOVATION Investor Presentation AUGUST 2023
10 Aug 23
8-K
The Oncology Institute Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance
8 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
16 Jun 23
Registration and prospectus
424B3
Prospectus supplement
10 Feb 23
424B3
Prospectus supplement
10 Feb 23
POS AM
Prospectus update (post-effective amendment)
27 Jan 23
POS AM
Prospectus update (post-effective amendment)
27 Jan 23
424B3
Prospectus supplement
9 Jan 23
POS AM
Prospectus update (post-effective amendment)
30 Dec 22
424B3
Prospectus supplement
1 Dec 22
424B3
Prospectus supplement
1 Dec 22
424B3
Prospectus supplement
1 Dec 22
424B3
Prospectus supplement
9 Nov 22
Other
EFFECT
Notice of effectiveness
10 Feb 23
EFFECT
Notice of effectiveness
10 Feb 23
EFFECT
Notice of effectiveness
9 Jan 23
EFFECT
Notice of effectiveness
27 Sep 22
EFFECT
Notice of effectiveness
6 Jun 22
EFFECT
Notice of effectiveness
4 May 22
EFFECT
Notice of effectiveness
14 Feb 22
CORRESP
Correspondence with SEC
9 Feb 22
CORRESP
Correspondence with SEC
4 Jan 22
CORRESP
Correspondence with SEC
3 Jan 22
Ownership
4
Change in insider ownership
30 Jan 24
4
Change in insider ownership
26 Jan 24
4
Change in insider ownership
23 Jan 24
144
Notice of proposed sale of securities
19 Jan 24
SC 13D/A
Havencrest Healthcare Partners, L.P.
2 Jan 24
4
Change in insider ownership
2 Jan 24
4
RICHARD A BARASCH
28 Dec 23
4
Brad Hively
28 Dec 23
4
Karen Marie Johnson
28 Dec 23
4
Mohit Kaushal
28 Dec 23